How to treat actinic keratosis? An update

Journal of Dermatological Case Reports

Volumn 9, Issue 2, 2015, Pages 29-35

  Costa, Claudia ^a   Scalvenzi, Massimiliano ^a   Ayala, Fabio ^a   Fabbrocini, Gabriella ^a   Monfrecola, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

5 fluorouracil; Actinic keratoses; Actinic keratosis; Diclofenac; Field cancerization; Imiquimod; Ingenol mebutate; Photodynamic therapy; Treatment

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DICLOFENAC; FLUOROURACIL; IMIQUIMOD; INGENOL MEBUTATE; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ACTINIC KERATOSIS; ARTICLE; BLISTER; CRYOTHERAPY; CURETTAGE; EROSION; ERYTHEMA; EXCISION; HEADACHE; HISTOLOGY; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNITY; INFECTION; INFLAMMATION; LIPID PEROXIDATION; LIVER TOXICITY; LOCAL SKIN REACTION; MEDICAL PROCEDURES; PAIN; PAPILLOMAVIRIDAE; PERIORBITAL EDEMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRURITUS; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOPHARYNGITIS; SKIN IRRITATION; SQUAMOUS CELL CARCINOMA; TOPICAL FIELD THERAPY;

EID: 84938348601     PISSN: None     EISSN: 18987249     Source Type: Journal    
DOI: 10.3315/jdcr.2015.1199     Document Type: Article

References (44)

1. Zalaudek I, Giacomel J, Schmid K, Bondino S, Rosendahl C, Cavicchini S, Tourlaki A, Gasparini S, Bourne P, Keir J, Kittler H, Eibenschutz L, Catricala C, Argenziano G. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J Am Acad Dermatol. 2012; 66: 589-597. PMID: 21839538.
2. Marks R, Jolley D, Dorevitch AP, Selwood TS. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust. 1989; 150: 475-478. PMID: 2786135.
3. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol. 1994; 131: 455-464. PMID: 7947197.
4. Stockfleth E, Sibbring GC, Alarcon I. New Topical Treatment Options for Actinic Keratosis: a Systematic Review. Acta Derm Venereol. 2015. doi: 10. 2340/00015555-2167. [Epub ahead of print]. PMID: 26068001.
5. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. Nonmelanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study. Br J Cancer. 1996; 74: 1308-1312. PMID: 8883423.
6. Holmes C, Foley P, Freeman M, Chong AH. Solar keratosis: epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol. 2007; 48: 67-74; quiz 75-6. Review. PMID: 17535191.
7. Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol. 2000; 115: 273-237. PMID: 10951246.
8. Yu RC, Pryce DW, Macfarlane AW, Stewart TW. A histopathological study of 643 cutaneous horns. Br J Dermatol. 1991; 124: 449-452. PMID: 2039721.
9. Butani AK, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma. Clin Plast Surg. 2005; 32: 223-235. Review. Erratum in: Clin Plast Surg. 2006; 33: 497. PMID: 15814119.
10. Rossi R, Mori M, Lotti T. Actinic teratosi. Int J Dermatol. 2007; 46: 895-904. PMID: 17822489.
11. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD Jr. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol. 1991; 146: 485-491. PMID: 1670944.
12. Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, Streilein JW. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol. 1990; 95: 530-536. PMID: 2230216.
13. Mortier L, Marchetti P, Delaporte E, Martin de Lassalle E, Thomas P, Piette F, Formstecher P, Polakowska R, Danze PM. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett. 2002; 176: 205-214. PMID: 11804749.
14. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Cancer Lett. 2008; 264: 145-161. PMID: 18331779.
15. Timares L, Katiyar SK, Elmets CA. DNA damage, apoptosis and langerhans cells-Activators of UV-induced immune tolerance. Photochem Photobiol. 2008; 84: 422-436. PMID: 18248501.
16. Berman B, Cockerell CJ. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol. 2013; 68 (1 Supp 1): PA1-A4, S10-S19. PMID: 23228301.
17. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc. 1996; 1: 136-142. Review. PMID: 9627707.
18. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single institution cohort study. JAMA Dermatol. 2013; 149: 541-547. PMID: 23677079.
19. Wang L, Eng W, Cockerell CJ. Effects of ultraviolet irradiation on inflammation in the skin. Adv Dermatol. 2002; 18: 247-286. PMID: 12528408.
20. Hruza LL, Pentland AP. Mechanisms of UV-induced inflammation. J Invest Dermatol. 1993; 100: 35S-41S. PMID: 8423392.
21. Berman B, Cockerell CJ. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol. 2013; 68 (1 Suppl 1): S10-S19. PMID: 23228301.
22. Lober BA, Lober CW, Accola J. Actinic keratosis is squamous cell carcinoma. J Am Acad Dermatol. 2000; 43 (5 Pt 1): 881-882. PMID: 11050603.
23. Heaphy MR Jr, Ackerman AB. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol. 2000; 43 (1 Pt 1): 138-150. PMID: 10863242.
24. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol. 2000; 42 (1 pt 2): 11-17. PMID: 10607351.
25. Lebwohl MG, Rosen T, Stockfleth E. The role of human papillomavirus in common skin conditions: current viewpoints and therapeutic options. Cutis. 2010; 86: Suppl 1-11; quiz suppl 12. PMID: 21214125.
26. Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 2000; 14: 3065-3073. PMID: 11114894.
27. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol. 2000; 42 (1 Pt 2): 11-17. Review. PMID: 10607351.
28. Padilla RS, Sebastian S, Jiang Z, Nindl I, Larson R. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression. Arch Dermatol. 2010; 146: 288-293. PMID: 20231500.
29. Neto PD, Alchorne M, Michalany N, Abreu M, Borra R. Reduced P53 Staining in Actinic Keratosis is Associated with Squamous Cell Carcinoma: A Preliminary Study. Indian J Dermatol. 2013; 58: 325. PMID: 23919015.
30. Dodds A, Chia A, Shumack S. Actinic keratosis: Rationale and Managment. Dermatol Ther (Heidelb). 2014; 4: 11-31. PMID: 24627245.
31. Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, Murrell D, Anderson C, Weightman W, Reid C, Watson A, Foley P. A prospective study of the use of cryosurgery for the treatment of actinic keratosis. Int J Dermatol. 2004; 43: 687-692. PMID: 15357755.
32. Kaufman R. The concept of field cancerization. Melanoma Res. 2010; 20: e13-e14.
33. de Berker D, McGregor JM, Hughes BR, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratosis. Br J Dermatol. 2007; 156: 222-230 (erratum in Br J Dermatol. 2008; 158: 873). PMID: 17223860.
34. McIntyre WJ, Downs MR, Bedwell SA. Treatment options for actinic keratosis. Am Fam Physician. 2007; 76: 667-671. PMID: 17894135.
35. Rahvar M, Lamel SA, Maibach HI. Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: an overview. Immunotherapy. 2012; 4: 939-945. Review. Erratum in: Immunotherapy. 2012; 4: 1898. Rhavar, Maral [corrected to Rahvar, Maral]. PMID: 23046237.
36. Schon MP, Schon M. Imiquimod: mode of action. Br J Dermatol. 2007; 157 Suppl 2: 8-13. Review. PMID: 18067624.
37. Gupta AK, Cooper EA, Abramovits W. Zyclara (imiquimod) cream, 3. 75%. Skinmed. 2010; 8: 227-229. PMID: 21137610.
38. Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratosis: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012; 66: 486-493. PMID: 22055282.
39. Siller G, Gebauer K, Welburn P, Katsamas J, Ogbourne SM. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study. Australas J Dermatol. 2009; 50: 16-22. PMID: 19178487.
40. Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stough DB, Katsamas J. Randomized, double-blind, doubledummy, vehicle-controlled study of ingenol mebutate gel 0. 025% and 0. 05% for actinic keratosis. J Am Acad Dermatol. 2009; 60: 934-943. PMID: 19467365.
41. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012; 366: 1010-1019. PMID: 22417254.
42. Lebwohl M, Shumack S, Stein Gold L, Melgaard A, Larsson T, Tyring SK. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratosis. JAMA Dermatol. 2013; 149: 666-670. PMID: 23553119.
43. Serra-Guillen C, Nagore E, Hueso L, Traves V, Messeguer F, Sanmartin O, Llombart B, Requena C, Botella-Estrada R, Guillen C. A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes. J Am Acad Dermatol. 2012; 66: e131-e137. PMID: 22226430.
44. Van der Geer S, Krekels GA. Treatment of actinic keratosis on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study. J Dermatolog Treat. 2009; 20: 259-265. PMID: 19370466.